Adene Sanchez | E+ | Getty Images Company: Exelixis (EXEL) Business: Exelixis, an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. They have produced four marketed pharmaceutical products, including their flagship molecule, cabozantinib. Stock Market Value: $6.3B ($19.46 per share) Activist: Farallon Capital
0 Comments
Li Auto (NASDAQ:LI) is one of several Chinese electric vehicle startups with a U.S. stock market listing on a major exchange. Alongside LI stock are Nio (NYSE:NIO) and Xpeng (NYSE:XPEV). U.S. investors follow all three. Yet while some looking to capitalize on EV adoption in China may want to spread their bets around, by buying
0 Comments
Chinese electric vehicle maker Nio (NYSE:NIO) has multiple positive catalysts, including the expected rapid growth of the Chinese EV sector and its sedans, which are quickly becoming quite popular in the huge Asian country. Moreover, the valuation of NIO stock is very low, and two reviews of its P7 luxury sedan that I found online are quite
0 Comments
Visit our website: https://www.zacks.com Visit our Stocktwits account: https://stocktwits.com/ZacksResearch Check out our weekly promotion: https://www.zacks.com/promo If you’re interested in our services, please check out Zacks Ultimate: https://www.zacks.com/ultimate/?adid=YOUTUBE&cid=sm-YOUTUBE
0 Comments
In this article JPM MOMO LCID BLK Follow your favorite stocksCREATE FREE ACCOUNT Getty Images Check out the companies making headlines in premarket trading. JPMorgan Chase – The banking behemoth popped more than 5% after posting record revenue that surpassed analyst expectations due to higher interest rates. JPMorgan Chase reported revenue of $39.34 billion, beating
0 Comments
Large, blue-chip dividend stocks are popular with investors due to their sleep-well-at-night qualities and ability to offer attractive, risk-adjusted, long-term wealth and income compounding. However, small-cap stocks have the potential to yield superior total returns. This is due to their higher growth potential and tendency to offer higher dividend yields. Indeed, small-cap stocks may involve
0 Comments
Among cannabis stocks, SNDL (NASDAQ:SNDL) has been one that screens well as a value play. Even though this Canada-based integrated cannabis company isn’t cheap on a price-to-earnings basis, SNDL stock has for quite some time traded at a discount to its tangible book value. But investors who have bought it based on its low valuation
0 Comments
Think bank earnings are boring? Not this quarter. Here’s what to watch for. Visit our website: https://www.zacks.com Visit our Stocktwits account: https://stocktwits.com/ZacksResearch Check out our weekly promotion: https://www.zacks.com/promo If you’re interested in our services, please check out Zacks Ultimate: https://www.zacks.com/ultimate/?adid=YOUTUBE&cid=sm-YOUTUBE
0 Comments
Is it possible for a retail apparel outlet to thrive when the economy is shaky? Yes, it is definitely possible as Burlington Stores (NYSE:BURL) caters to discount hunters, an advantage during elevated inflation. Sure, it’s somewhat risky to invest in retail apparel stocks, but Burlington’s favorable current-quarter outlook indicates BURL stock could run higher. Headquartered
0 Comments
With inflation falling to 5%, the expectations for sustained rate hikes have fallen considerably. Even though core inflation did rise and the labor market remains strong, the Federal Reserve, for now, is unlikely to hike interest rates further. That’s great for high-cyclical growth stocks, many of which have rebounded substantially this year. However, many stocks
0 Comments
It’s fine to seek out low-priced tech stocks, but I definitely do not recommend Exela Technologies (NASDAQ:XELA) stock. Exela Technologies has financial problems and the company’s shares are at risk of being delisted from the Nasdaq exchange. So, there’s too much risk to justify an investment in Exela Technologies. Headquartered in Texas, Exela Technologies specializes in business
0 Comments